Literature DB >> 21816508

Understanding commonly encountered limitations in clinical research: an emergency medicine resident's perspective.

Christopher W Jones1, Timothy F Platts-Mills.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21816508      PMCID: PMC3539753          DOI: 10.1016/j.annemergmed.2011.05.024

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


× No keyword cloud information.
  30 in total

1.  Toward evidence-based medical statistics. 1: The P value fallacy.

Authors:  S N Goodman
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

Review 2.  Validity of composite end points in clinical trials.

Authors:  Victor M Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J Schünemann; Roman Jaeschke; Gordon H Guyatt
Journal:  BMJ       Date:  2005-03-12

3.  Contradicted and initially stronger effects in highly cited clinical research.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2005-07-13       Impact factor: 56.272

Review 4.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Authors:  Stephan Heres; John Davis; Katja Maino; Elisabeth Jetzinger; Werner Kissling; Stefan Leucht
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

Review 5.  The case of the misleading funnel plot.

Authors:  Joseph Lau; John P A Ioannidis; Norma Terrin; Christopher H Schmid; Ingram Olkin
Journal:  BMJ       Date:  2006-09-16

6.  Origin and funding of the most frequently cited papers in medicine: database analysis.

Authors:  Nikolaos A Patsopoulos; John P A Ioannidis; Apostolos A Analatos
Journal:  BMJ       Date:  2006-03-17

7.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

8.  Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction.

Authors:  S M Horner
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

9.  ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

10.  Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache.

Authors:  Brian H Rowe; Ian Colman; Marcia L Edmonds; Sandra Blitz; Alan Walker; Sheldon Wiens
Journal:  Headache       Date:  2007-11-28       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.